Recent changes
Track the most recent changes to the wiki on this page.
18 April 2019
- (diff | hist) . . N Interferon gamma; 22:02 . . (+2,418) . . Prab (Talk | contribs) (Created page with "{{intro}} Interferon gamma is a recombinant cytokine with a multitude of actions including stimulation of T cell immunity, increase in innate immune responses, induction of Cl...")
- (diff | hist) . . N Denileukin Diftitox; 21:59 . . (+1,935) . . Prab (Talk | contribs) (Created page with "{{intro}} Denileukin diftitox is a recombinant fusion protein of human interleukin-2 (IL-2) attached to diphtheria toxin fragments A and B that is used as an antineoplastic ag...")
- (diff | hist) . . N Aldesleukin; 21:58 . . (+2,427) . . Prab (Talk | contribs) (Created page with "{{intro}} Aldesleukin is a recombinant form of human interleukin-2, a cytokine that stimulates the proliferation and maturation of T cells, which is used in immune therapy of ...")
- (diff | hist) . . N Biologic Response Modifiers; 21:50 . . (+1,017) . . Prab (Talk | contribs) (Created page with "'''Biological response modifier therapy''' (BY-oh-LAH-jih-kul reh-SPONTS MAH-dih-FY-er THAYR-uh-pee) A type of treatment that uses substances made from living organisms to t...")
- (diff | hist) . . N Trifluridine/Tipracil; 21:45 . . (+2,330) . . Prab (Talk | contribs) (Created page with "{{intro}} Trifluridine/tipiracil is the combination of an antineoplastic pyrimidine analogue (trifluridine) with an inhibitor of its metabolism (tipiracil) that is used in the...")
- (diff | hist) . . Gemcitabine; 21:44 . . (+1,726) . . Prab (Talk | contribs)
- (diff | hist) . . Fluorouracil; 21:42 . . (+2,214) . . Prab (Talk | contribs)
- (diff | hist) . . N Floxuridine; 21:40 . . (+1,883) . . Prab (Talk | contribs) (Created page with "{{intro}}Floxuridine (FUDR) is a pyrimidine analogue used as an antineoplastic agent, usually as a continuous hepatic arterial infusion to treat hepatic metastases from colon ...")
- (diff | hist) . . Template:Stubd; 21:36 . . (+5) . . Prab (Talk | contribs) (→{{PAGENAME}} information)
- (diff | hist) . . Decitabine; 21:35 . . (+1) . . Prab (Talk | contribs)
- (diff | hist) . . N Decitabine; 21:35 . . (+1,667) . . Prab (Talk | contribs) (Created page with "{{intro}}Decitabine is a cytosine analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes. {{livtox}} Decitabine is...")
- (diff | hist) . . Cytarabine; 21:34 . . (-3) . . Prab (Talk | contribs)
- (diff | hist) . . Cytarabine; 21:33 . . (-1) . . Prab (Talk | contribs)
- (diff | hist) . . N Cytarabine; 21:33 . . (+1,711) . . Prab (Talk | contribs) (Created page with "{{intro}}Cytarabine is a cytosine analogue and antineoplastic agent used largely in the therapy of acute leukemia. {{livtox}} Cytarabine is associated with a low rate ...")
- (diff | hist) . . Template:Cancer drugs; 21:29 . . (+2) . . Prab (Talk | contribs)
- (diff | hist) . . Capecitabine; 21:27 . . (-8,081) . . Prab (Talk | contribs)
- (diff | hist) . . Template:Cancer drugs; 21:24 . . (+127) . . Prab (Talk | contribs)
- (diff | hist) . . Azacitidine; 21:03 . . (-1) . . Prab (Talk | contribs)
- (diff | hist) . . Azacitidine; 21:03 . . (+1,814) . . Prab (Talk | contribs)
- (diff | hist) . . Antineoplastic Agents; 20:49 . . (0) . . Prab (Talk | contribs)
- (diff | hist) . . N Pyrimidine Analogues; 20:48 . . (+3,260) . . Prab (Talk | contribs) (Created page with "{{intro}} The pyrimidine analogues, used as antineoplastic agents, are a diverse group of agents with similar structures but somewhat different mechanisms of action, activ...")
- (diff | hist) . . Thioguanine; 20:45 . . (+1,490) . . Prab (Talk | contribs)
- (diff | hist) . . Pentostatin; 20:42 . . (-5) . . Prab (Talk | contribs)
- (diff | hist) . . N Pentostatin; 20:41 . . (+1,866) . . Prab (Talk | contribs) (Created page with "{{intro}} Pentostatin is a purine analogue and antineoplastic agent used in the therapy of hairy cell leukemia and T cell lymphomas. {{livtox}} Pentostatin is as...")
- (diff | hist) . . N Nelarabine; 20:40 . . (+1,953) . . Prab (Talk | contribs) (Created page with "{{intro}} Nelarabine is a purine analogue and antineoplastic agent used in the therapy of T cell lymphoblastic leukemia or lymphoma. {{livtox}} Nelarabine is ...")
- (diff | hist) . . Mercaptopurine; 20:38 . . (-6) . . Prab (Talk | contribs)
- (diff | hist) . . Mercaptopurine; 20:37 . . (+1,635) . . Prab (Talk | contribs)
- (diff | hist) . . N Fludarabine; 20:26 . . (+2,365) . . Prab (Talk | contribs) (Created page with "{{intro}} Fludarabine is a purine analogue and antineoplastic agent used in the therapy of chronic lymphocytic leukemia (CLL) and in immunosuppressive regimens in pre...")
- (diff | hist) . . N Clofarabine; 20:22 . . (+1,941) . . Prab (Talk | contribs) (Created page with "{{intro}} Clofarabine is a purine analogue and antineoplastic agent used in the therapy of acute lymphoblastic leukemia (ALL) in children. {{livtox}} Clofarabine ...")
- (diff | hist) . . N Cladribine; 20:20 . . (+1,900) . . Prab (Talk | contribs) (Created page with "{{intro}} Cladribine is a purine analogue and antineoplastic agent used primarily in the therapy of hairy cell leukemia. {{livtox}} Cladribine is typically given intrav...")
- (diff | hist) . . Azathioprine; 20:18 . . (-610) . . Prab (Talk | contribs) (→Pharmacokinetics)
- (diff | hist) . . Azathioprine; 20:17 . . (-2,050) . . Prab (Talk | contribs)
- (diff | hist) . . Azathioprine; 20:16 . . (-121) . . Prab (Talk | contribs) (→Adverse effects)
- (diff | hist) . . Purine Analogues; 20:16 . . (-1) . . Prab (Talk | contribs)
- (diff | hist) . . N Purine Analogues; 20:15 . . (+3,021) . . Prab (Talk | contribs) (Created page with "{{intro}} The purine analogues used as antineoplastic agents are a group of agents with similar structures, but somewhat different mechanisms of action, pharmacokinetics, indi...")
- (diff | hist) . . N Trimetrexate; 20:11 . . (+2,792) . . Prab (Talk | contribs) (Created page with "{{intro}} Trimetrexate is a parenterally administered folate antagonist that is used as a second line therapy for severe Pneumocystis jirovecii (previously carinii) pneumonia....")
- (diff | hist) . . Pralatrexate; 20:08 . . (-1) . . Prab (Talk | contribs)
- (diff | hist) . . N Pralatrexate; 20:08 . . (+1,762) . . Prab (Talk | contribs) (Created page with "{{intro}} Pralatrexate is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of peripheral T cell lymphomas. liver in...")
- (diff | hist) . . N Antifolates; 20:05 . . (+308) . . Prab (Talk | contribs) (Created page with "Antifolates such as Methotrexate is an antineoplastic and immunosuppressive agent widely used in the therapy of leukemia, lymphoma, solid tumors, psoriasis...")
- (diff | hist) . . N Fistula discharge; 19:04 . . (+51) . . Tpr (Talk | contribs) (Created page with "The leakage of a substance from a fistula. {{stub}}")
- (diff | hist) . . N Fissuring; 19:04 . . (+36) . . Tpr (Talk | contribs) (Created page with "A narrow break in the skin. {{stub}}")
- (diff | hist) . . N Fisher syndrome; 19:03 . . (+109) . . Tpr (Talk | contribs) (Created page with "An autoimmune process characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia. {{stub}}")
- (diff | hist) . . N First trimester antepartum hemorrhage; 19:03 . . (+85) . . Tpr (Talk | contribs) (Created page with "Excessive blood loss within the first trimester but prior to onset of labor. {{stub}}")
- (diff | hist) . . N First relapse; 19:03 . . (+141) . . Tpr (Talk | contribs) (Created page with "The reemergence of a disorder as diagnosed by clinical and/or laboratory evidence following a single documented period of remission. {{stub}}")
- (diff | hist) . . N First feeding; 19:02 . . (+61) . . Tpr (Talk | contribs) (Created page with "The first time that a neonate is provided nutrition. {{stub}}")
- (diff | hist) . . N First degree perineal laceration; 19:02 . . (+51) . . Tpr (Talk | contribs) (Created page with "Injury to perineal skin only. (revitalize) {{stub}}")
- (diff | hist) . . N First degree burn; 19:01 . . (+157) . . Tpr (Talk | contribs) (Created page with "A painful injury to the epidermis due to chemical, friction, radiation or thermal exposure. The affected area appears red and blanches when touched. {{stub}}")
- (diff | hist) . . N Finnegan score measurement; 19:01 . . (+179) . . Tpr (Talk | contribs) (Created page with "A tool to evaluate neonatal abstinence syndrome (nas), that measures the degree to which a neonate is experiencing symptoms of withdrawal due to maternal substance abuse. {{st...")
- (diff | hist) . . N Fine motor delay; 18:59 . . (+106) . . Tpr (Talk | contribs) (Created page with "Delayed acquisition of age appropriate motor milestones that produce small and precise movements. {{stub}}")
- (diff | hist) . . N Finding; 18:59 . . (+87) . . Tpr (Talk | contribs) (Created page with "Clinical, laboratory or molecular evidence, or absence of evidence of disease. {{stub}}")
